Pentwater Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Pentwater Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,781,778	Closed	-$80.6M	–	124
2024 Q1	$80.6M	Buy	+3,781,778	New	+$45.2M	0.83%	20

Pentwater Capital Management's FUSN Position: Q2 2024 in Review

Pentwater Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 3,781,778 shares — an estimated $80.6M sold.

Pentwater Capital Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $80.6M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Pentwater Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Pentwater Capital Management sold 3,781,778 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $80.6M.
Pentwater Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Pentwater Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $80.6M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Pentwater Capital Management's 13F filing for Q2 2024, filed 31 Jul 2024.